SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ben Wa who wrote (4514)6/12/2003 6:43:30 PM
From: StockDung  Read Replies (2) of 5582
 
TOP SECRET SLEEP SPRAY TO REACH MARKET!

===================================================
Med Gen to Start Marketing New Liquid Sleep Aid
Monday June 9, 11:23 am ET

BOCA RATON, Fla.--(BUSINESS WIRE)--June 9, 2003--Med Gen Inc. (OTCBB:MDGN - News), makers of the now well known brand Snorenz®, all natural liquid snoring relief formula now sold in over 35,000 stores world wide, will introduce its new, first ever, liquid sleep aid product to its retail accounts starting July 10th, 2003.
GoodNights Sleep(TM) has been under development by the company for over one year and kept under a blanket of top secrecy as it will be the first liquid spray of its kind, competing with a plethora of pill and capsule sleep aide products. The liquid spray application, using its special manufacturing process, is designed to enter the body faster and easier through absorption by the mucous membrane in the throat thus delivering its dosage directly into the blood stream without going into the stomach and the liver where pills and capsules lose a lot of their potency.

The market for over the counter sleep aid products exceeds $350 million in the United States alone, the worldwide market place is said to exceed $1.7 Billion. The company intends to market GoodNights Sleep(TM) through its regular channels of distribution and the product has already been accepted in three major chains for early distribution. Because of its success with Snorenz®, the company expects that it will quickly reach the shelves of the 35,000 stores now distributing Snorenz®.

Med Gen President Paul S. Mitchell said he expects to reach 1% of the existing market ($350 Million) by the first year. Thus adding $3.5 million in sales or doubling 2002 sales figures is a good projection for the first 12 months sales. Mr. Mitchell added that the sales are wide open for this kind of product that is now dominated by Sominex®, ExcedrinPM® and other "pill" products and he reports that the company has already received its first purchase order from Albertson's for immediate delivery. The market for sleep aid products is a fast growing market.

This Press Release contains or incorporates by reference "forward looking" statements including certain information with respect to plans and strategies of Med Gen Inc. ("MedGen®"). For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of MedGen® operations that could differ materially from those indicated by such forward looking statements.

MedGen® is a publicly traded company on the OTCBB exchange "MDGN".

--------------------------------------------------------------------------------
Contact:
Med Gen Inc., Boca Raton
Paul Kravitz, 561/750-1100
medgen.com
forgoodnightssleep.com
thehealthytimes.com

============================================

AND LAST BUT NOT LEAST, EXCUSE ME.... I MEANT TO SAY FINALLY

thehealthytimes.com

--------------------------------------------

ALSO SEE;

--------------------------------------------------------------------------------


1: Tru-Vantage International, LLC/Med Gen, Inc.
truvanmedgen.htm, Search in: News_Releases
File size: 13K, Create Date: Aug-27-02 14:29
ftc.gov



2: Announced Actions for July 19, 2002
fyi0240.htm, Search in: News_Releases
File size: 12K, Create Date: Apr-01-03 16:52
ftc.gov



3: Eye Doctor That Purportedly Conducted Tests to Support The Efficacy of a Product to Treat Snoring Settles FTC Charges
currier.htm, Search in: News_Releases
File size: 12K, Create Date: Nov-06-02 09:45
ftc.gov



4: News Releases: July 2002
index.htm, Search in: News_Releases
File size: 17K, Create Date: Aug-12-02 07:35
ftc.gov
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext